جستجوی استاد راهنمای دانشگاهی

John P.A. Ioannidis is the C.F. Rehnborg Professor in Disease Prevention and Professor of Medicine, Health Research and Policy, Biomedical Data Science, and Statistics at Stanford University. He is Co-Director of the Meta-Research Innovation Center at Stanford (METRICS) and an Einstein BIH Visiting Fellow at Charité - Universitätsmedizin Berlin. His academic appointments span multiple departments and institutes at Stanford, including the Stanford Prevention Research Center, Biomedical Data Science, and Statistics. He is internationally recognized for his work in meta-research, evidence-based medicine, and research reproducibility. Ioannidis holds an MD and DSc in Biopathology from the National University of Athens, with training in internal medicine and infectious diseases from Harvard and Tufts. He previously chaired the Department of Hygiene and Epidemiology at the University of Ioannina Medical School and held adjunct positions at Harvard, Tufts, and Imperial College. He joined Stanford in 2010, where he launched the PhD program in Epidemiology & Clinical Research, the MS in Community Health & Prevention Research, and METRICS in 2014. His research focuses on improving research methods, appraising biases, enhancing reproducibility, and integrating evidence across scientific disciplines. He is a pioneer in meta-research, with seminal contributions on the reliability of published findings, statistical practices, and research synthesis. His influential 2005 paper, "Why Most Published Research Findings Are False," is the most-accessed article in PLoS history. His recent work examines peer review, data sharing, AI in medicine, and pandemic research impact, consistently advocating for transparency and methodological rigor. His publications span epidemiology, statistics, genomics, clinical trials, and meta-analysis, with a strong emphasis on bias detection, replication, and open science. Trends in his recent articles highlight concerns about research integrity, citation practices, peer review reform, and the scientific response to global health crises. Founders' Medal for Lifetime Contributions to Meta-science (2024) Honorary doctorates from McMaster, Thessaloniki, Edinburgh, Tilburg, Athens, and Rotterdam Elected member, US National Academy of Medicine (2018) Elected member, European Academy of Sciences and Arts (2015) President, Association of American Physicians (2023–2024) President, Society for Research Synthesis Methodology Gordon Award, NIH (2019) Chanchlani Global Health Award (2017) Highly Cited Researcher (Clarivate) in Clinical Medicine, Social Sciences, and Psychiatry Ioannidis has advised numerous students and mentored early-career researchers. He has served as Senior Advisor for Knowledge Integration at the National Cancer Institute (2012–2016) and Editor-in-Chief of the European Journal of Clinical Investigation (2010–2019). He has received over 700 invited lectures and is deeply involved in shaping research policy and scientific infrastructure. He leads METRICS, a hub for meta-research innovation, and is affiliated with multiple Stanford institutes, including Bio-X, the Cardiovascular Institute, and the Stanford Cancer Institute.

• Meta-research
• Evidence-based Medicine
• Research Reproducibility
• +۱۲ مورد دیگر

Lindsey Draper, MD serves as an Adjunct Instructor in the Roybal Laboratory within the Department of Medicine, Division of Hematology and Oncology at the University of California San Francisco School of Medicine. Her clinical practice focuses on the treatment of patients with recurrent ovarian cancer using systemic therapies including chemotherapy and immunotherapy, with a commitment to evaluating and offering clinical trial opportunities as part of individualized patient care. Dr. Draper completed her educational training with a B.S. in Biology from Juniata College (2010), an M.D. from the University of Maryland School of Medicine (2017), an Internal Medicine Residency at The Mount Sinai Hospital (2022), and is currently completing a Medical Oncology Fellowship at UCSF (2025-2027). Her research interests center on cancer immunotherapy, particularly T cell-based approaches for HPV-associated cancers and ovarian cancer. She investigates engineered T cell therapies targeting viral antigens in cervical and other HPV-related cancers, with a focus on overcoming treatment resistance and improving clinical outcomes through novel immunotherapeutic strategies. Her work bridges fundamental immunological mechanisms with clinical applications, emphasizing the translation of laboratory discoveries into patient treatments. Dr. Draper's publication record demonstrates consistent contributions to the field of cancer immunotherapy, with recent work focusing on TCR-engineered T cells for leukemia and HPV-associated malignancies. Her research trajectory shows increasing sophistication in T cell engineering approaches and a growing emphasis on addressing inflammatory responses and treatment resistance mechanisms. Parker Institute for Cancer Immunotherapy Early Career Research Award: Parker Scholar (2024) Gladstone-UCSF Institute of Genomic Immunology Symbiont Seed Grant for 'Antigen Discovery for Ovarian Cancer' (2024) Conquer Cancer Young Investigator Award, American Society of Clinical Oncology (2024) Women in Cancer Immunotherapy Network Leadership Institute Selected Participant, Society for Immunotherapy of Cancer (2024) Physician-Scientist Fellow, Chan Zuckerberg Biohub - San Francisco (2023-2025) As a physician-scientist, Dr. Draper maintains an active research program while providing clinical care, with particular emphasis on developing novel immunotherapies for gynecologic cancers. Her current fellowship at UCSF and multiple early-career awards indicate strong potential for continued contributions to the field of cancer immunotherapy. Dr. Draper works within the Roybal Laboratory at UCSF, which focuses on innovative approaches to cancer immunotherapy and T cell engineering. Her research intersects with multiple collaborative initiatives at UCSF, including the Parker Institute for Cancer Immunotherapy and the Gladstone-UCSF Institute of Genomic Immunology.

• Cancer Immunotherapy
• Ovarian Cancer
• HPV-Associated Cancers
• +۵ مورد دیگر

Dr. Frank Rudzicz is an Associate Professor in the Faculty of Computer Science at Dalhousie University. His research lies at the intersection of artificial intelligence, natural language processing, and healthcare, with a focus on developing machine learning systems that improve clinical decision-making, patient outcomes, and accessibility in medicine. He holds a BSc from Concordia University (2004), an MEng from McGill University (2006), and a PhD from the University of Toronto (2011). His research interests include Natural Language Processing, Machine Learning, Healthcare, Speech Technologies, Explainable AI, and Fairness in ML. Dr. Rudzicz's recent publications span a wide range of topics, including Alzheimer's detection through speech analysis, surgical outcome prediction, mental health monitoring, privacy in AI, and the application of large language models in clinical settings. His work consistently emphasizes ethical AI, patient privacy, and real-world clinical integration. He has received several awards, including a Best Paper award at EMNLP 2020, a Best Student Paper award at ICASSP 2021, and the ISCA Best Student Paper award in 2013. His research has been published in top-tier journals such as Nature Scientific Reports , JAMA Network Open , IEEE Access , and Frontiers in Human Neuroscience , as well as leading conferences including NeurIPS, ACL, ICML, and Interspeech. Dr. Rudzicz supervises a dynamic research group working on AI for health, with active projects in voice-based diagnostics, ambient clinical documentation, explainable AI for surgery, and wearable-based monitoring for chronic diseases. He collaborates widely across disciplines, including with clinicians, neuroscientists, ethicists, and public health experts. He is also involved in major initiatives such as the Genetics Navigator study and Bridge2AI-Voice, aiming to build ethically sourced, diverse biomedical datasets. His lab actively explores the societal implications of AI in healthcare, including fairness, trust, and resistance to malicious fine-tuning.

• Natural Language Processing
• Machine Learning
• Healthcare
• +۱۲ مورد دیگر

Dr. Lucian Sulica is the Sean Parker Professor of Laryngology and Director of the Sean Parker Institute for the Voice at Weill Cornell Medical College. He is an attending Otolaryngologist at NewYork-Presbyterian Hospital with a clinical practice exclusively focused on voice disorders. Dr. Sulica served as the 2023 President of the American Laryngological Association and is a Fellow of the American Laryngologic, Rhinologic and Otologic Society (the Triologic Society). His educational background includes: A.B. from Dartmouth College (1989) M.D. from Georgetown University School of Medicine (1993) Residency at Georgetown University Medical Center Fellowship at New York Center for Voice & Swallowing Disorders, St. Luke's-Roosevelt Hospital Center Dr. Sulica's research focuses on evidence-driven principles for treating voice conditions, with particular emphasis on vocal fold injuries from voice use (especially in performers), neurologic voice disorders (including vocal fold paralysis, spasmodic dysphonia, and tremor), and in-office procedures for voice disorders that don't require general anesthesia. His work has addressed critical aspects such as gender differences in vocal fold injury, pathophysiology of laryngeal nerve injury, and diagnostic accuracy in voice disorders. Analysis of Dr. Sulica's recent publications reveals a strong focus on advancing diagnostic techniques through artificial intelligence, improving surgical outcomes for vocal fold lesions, understanding performers' unique voice care needs, and developing evidence-based protocols for vocal fold hemorrhage and other voice disorders. His research increasingly incorporates technology-driven approaches while maintaining a strong clinical focus on patient-centered outcomes. Dr. Sulica has received numerous prestigious awards including: Casselberry Award of the American Laryngological Association (2021) Felix Semon Lectureship in Laryngology, Royal Society of Medicine (2022) American Academy of Otolaryngology – Head & Neck Surgery Honor Award (2008) Consistent recognition as one of "Best Doctors in America" (2005-2024) Designation as one of "America's Top Physicians in Voice Disorders/Laryngology" (since 2006) Inclusion in "New York Magazine Best Doctors" list annually since 2013 As an educator, Dr. Sulica has authored more than 110 journal articles and 40 book chapters, and has edited three books including "Vocal Fold Paralysis," "Classics in Voice and Laryngology," and "Patologia Laringea y Fonocirugia" (in Spanish). He is passionate about teaching and has lectured extensively across the United States, Europe, Latin America, and Australia. His clinical work at the Sean Parker Institute for the Voice represents a comprehensive approach to voice care, incorporating innovative in-office procedures that have helped establish new standards in laryngology.

• Voice Disorders
• Laryngology
• Vocal Fold Injuries
• +۷ مورد دیگر

Benjamin Andrew Toll is a Professor in the Department of Public Health Sciences and Psychiatry at the Medical University of South Carolina (MUSC) College of Medicine. He serves as Associate Director of Education and Training for the Hollings Cancer Center, Vice Chair of Research in the Department of Public Health Sciences, Co-Director of the Lung Cancer Screening Program, and Director of the Tobacco Treatment Program at MUSC. Dr. Toll received his BA from Cornell University (1996), MS and PhD from Nova Southeastern University (1999, 2002), and completed his Postdoctoral Fellowship and Internship at Yale University. Dr. Toll is a leading researcher in tobacco cessation, with over 20 years of experience conducting clinical trials focused on developing novel therapeutics for tobacco and nicotine use. His work primarily centers on preventing cancer through tobacco treatment interventions, with particular emphasis on lung cancer screening patients and cancer surgery patients. He has expertise in nicotine replacement therapy, contingency management approaches, gain-framed messaging, and digital health interventions for smoking cessation across diverse populations including older adults and young adults. His recent publications demonstrate a strong focus on implementation science for tobacco treatment programs across various healthcare settings including hospitals, oncology clinics, and primary care. His research examines barriers to treatment, optimal delivery methods (including telehealth and EHR-integrated tools), and effectiveness of various pharmacological and behavioral interventions for smoking cessation. National Cancer Institute funding (R01CA235697, R01CA207229, P50CA196530) National Institute on Drug Abuse funding (P50DA036151, K12DA000167) Continuous funding for over 15 years for tobacco cessation research As a mentor and leader, Dr. Toll oversees the Education and Training program at the Hollings Cancer Center, guiding the development of future cancer researchers. His Tobacco Treatment Program serves as a model for integrating tobacco cessation into comprehensive cancer care, and he has successfully implemented 'opt-out' tobacco treatment programs across multiple hospital systems in South Carolina. Dr. Toll leads a multidisciplinary research team focused on tobacco treatment, including psychologists, pharmacists, physicians, and implementation scientists working together to develop and test innovative approaches to smoking cessation for high-risk populations.

• Tobacco Cessation
• Smoking Cessation
• Cancer Prevention
• +۵ مورد دیگر

Melanie Molina, MD, MAS is an Assistant Professor of Emergency Medicine at the University of California, San Francisco (UCSF) and Affiliate Faculty of the Philip R. Lee Institute for Health Policy Studies. She serves as Co-Director of the Social Emergency Medicine and Health Equity Section and holds a secondary appointment in the Department of Medicine’s Division of Clinical Informatics and Digital Transformation. Clinically, she works at Zuckerberg San Francisco General Hospital and UCSF Medical Center. National Clinician Scholars Program Fellowship (2023) MAS in Clinical Research, UCSF (2023) Residency in Emergency Medicine, Harvard Medical School (2021) MD in Medicine, The University of Texas at Austin (2017) BS/BA in Biology and Hispanic Studies, The University of Texas at Austin (2012) Dr. Molina’s research centers on leveraging technology to address social determinants of health in emergency settings, with a focus on vulnerable populations. Her work spans health equity, opioid use disorder interventions, microaggressions in healthcare, and clinical informatics. She pioneers EHR-enabled tools to integrate social care into emergency clinical workflows while minimizing clinician burden. Her NIH-funded projects emphasize practical solutions for racial and ethnic health disparities, particularly in vaccine delivery and social risk documentation. Her recent publications (2024-2025) reveal three dominant trends: (1) Integration of AI and informatics for social risk screening and clinical decision support, (2) Health equity interventions targeting vaccine hesitancy and long COVID disparities, and (3) Critical analysis of DEI implementation challenges in academic emergency medicine. The work consistently bridges technical innovation with community-centered approaches to address systemic inequities. National Institutes of Health NIDA Loan Repayment Award (2024-2025) National Hispanic Medical Association Top 40 Under 40 (2024) UCSF John A. Watson Faculty Scholar (2023) National Institutes of Health NIAID Loan Repayment Award (2022-2024) Academy for Women in Academic Emergency Medicine Outstanding Research Publication Award (2021) Harvard Medical School Presidential Scholars Public Service Initiative Award (2017) Dr. Molina actively mentors medical students, residents, and fellows in health equity research. As Principal Investigator on multiple NIH and foundation grants—including the Harold Amos Medical Faculty Development Program grant ($825,575, 2024-2028) and an NIH/NIDA K23 award (2024-2029)—she leads projects developing EHR-integrated interventions for social risk documentation and opioid use disorder treatment. Her PROBOOSTVAXED trial addresses vaccine hesitancy through ED-based delivery across eight U.S. cities. She co-directs the Social Emergency Medicine and Health Equity Section within UCSF’s Department of Emergency Medicine, collaborating closely with the Action Research Center for Health Equity and the Philip R. Lee Institute for Health Policy Studies. Her team integrates clinical informatics expertise with community health workers to develop scalable solutions for social risk mitigation in safety-net emergency departments.

• Health Equity
• Health Disparities
• Vulnerable Populations
• +۵ مورد دیگر

Heather A. Jones, Ph.D., serves as Associate Professor in the Department of Psychology within Virginia Commonwealth University's College of Humanities and Sciences, holding joint appointments with the Department of African American Studies, Department of Pediatrics, and Institute for Women's Health. As a licensed clinical psychologist in Virginia, she maintains an active research program focused on reducing mental health disparities through culturally responsive interventions. Ph.D. in Psychology, University of Maryland at College Park (2006) Dr. Jones' research centers on three interconnected pillars: Black children and families' mental health, maternal mental health across the perinatal spectrum, and training culturally competent clinical psychologists. Her work specifically examines ADHD manifestations in Black youth, impacts of racial discrimination on adolescent mental health, and integration of behavioral health services within primary care settings. She employs mixed-methods approaches to address systemic barriers in mental healthcare access for underserved communities. Analysis of her 2023-2025 publications reveals consistent emphasis on health equity through studies of cultural competence in cancer survivorship, ADHD treatment representation gaps, and digital interventions for perinatal depression. Her methodological approaches span latent class analyses of service utilization, content analyses of historical research biases, and clinical trials of integrated care models, all contextualized within structural determinants of health. Dr. Jones has received significant recognition for her contributions: VCU College of Humanities and Sciences Distinguished Teaching Award (2023) VCU Department of Psychology Outstanding Mentoring Award (2023) Elizabeth Fries Young Investigator Award (2016) Clinical and Translational Research Award (2016) She actively mentors students, particularly supporting Black graduate trainees in pediatric psychology as evidenced by numerous student co-authorships. As Principal Investigator, she directs the $1.4M HRSA-funded Primary Care Psychology Training Collaborative providing pro bono services to urban Richmond and rural Virginia communities, recently expanded through an additional $1.1M grant serving Latinx immigrants and refugees. Her federally funded work consistently bridges research, clinical service, and community engagement. Dr. Jones co-directs the Families and Mental Health Research Lab and Primary Care Psychology Training Collaborative, leading interdisciplinary teams comprising psychology graduate students, pediatric residents, and community health workers. These initiatives operate within VCU's integrated primary care clinics, focusing on implementation science to scale evidence-based practices for underserved populations while training the next generation of healthcare providers.

• Child and Parental Mental Health
• Black Children and Families
• Maternal Mental Health
• +۳ مورد دیگر

Daryl Cameron is an Associate Professor of Psychology at The Pennsylvania State University and the Sherwin Early Career Professor in the Rock Ethics Institute (2023-2026). He serves as the Social Area Coordinator in the Department of Psychology and is a Senior Research Associate in the Rock Ethics Institute. His interdisciplinary work bridges psychology, philosophy, and neuroscience to investigate empathy and moral decision-making. His educational background includes: Ph.D. in Psychology, University of North Carolina at Chapel Hill, 2013 M.A. in Psychology, University of North Carolina at Chapel Hill, 2009 B.A. in Philosophy and Psychology, College of William and Mary, 2006 Cameron's research centers on the psychological mechanisms of empathy and moral judgment, investigating motivational and situational factors that shape empathic responses in contexts like mass suffering and intergroup conflict. His lab employs affective science , social cognition , and moral philosophy to study empathy regulation toward humans, animals, and artificial intelligence. Key findings reveal that people often avoid empathy due to perceived cognitive costs, and he explores creative interventions to foster compassionate responses across diverse populations including students, community adults, voters, patients, and physicians. Analysis of his 2019-2025 publications shows consistent focus on empathy regulation, moral judgment, and cognitive underpinnings of prosocial behavior, with emerging emphasis on artificial intelligence and animal ethics. His work spans social psychology , cognitive science , and applied ethics , demonstrating how cognitive load influences empathy choices, the dynamics of moral outrage in social media, and cross-species empathic decision-making. Cameron has received the following scientific awards: Sherwin Early Career Professor, Rock Ethics Institute (2023-2026) While specific grant awards and doctoral advisee lists are not detailed in source materials, Cameron's leadership of two major research initiatives—the Empathy and Moral Psychology Laboratory and the Consortium on Moral Decision-Making—demonstrates active mentorship and research funding acquisition. His laboratory explicitly recruits trainees from psychology, philosophy, neuroscience, and related disciplines, reflecting commitment to interdisciplinary training. Cameron directs the Empathy and Moral Psychology Laboratory (https://emplab.la.psu.edu/), which investigates empathy mechanisms using implicit measurement and mathematical modeling, and leads the Consortium on Moral Decision-Making (https://moralconsortium.psu.edu/), an interdisciplinary network advancing research on empathy and moral decisions across diverse contexts and populations.

• Empathy
• Moral Psychology
• Social Cognition
• +۳ مورد دیگر

Lee H. Schwamm, MD is Associate Dean for Digital Strategy and Transformation at Yale School of Medicine and Senior Vice President & Chief Digital Health Officer for Yale New Haven Health System. He holds professorships in both Biomedical Informatics & Data Sciences and Neurology at Yale School of Medicine. Previously, he spent three decades at Mass General Brigham Health System where he served as Executive Vice Chair of Neurology, Director of the Center for TeleHealth at Massachusetts General Hospital, and Vice President for Digital Patient Experience and Virtual Care. Dr. Schwamm is an internationally recognized expert in stroke diagnosis, treatment and prevention, with particular expertise in telestroke and digital health applications in neurology. His research focuses on stroke in young patients, cryptogenic strokes, patterns of stroke care delivery, and addressing health inequities in stroke outcomes. He has been a pioneer in telehealth, especially in telestroke services, and has served as a policy advisor for the American Heart Association. His work has resulted in over 500 peer-reviewed publications with recent research emphasizing digital health solutions, AI applications in stroke care, social determinants of health impacts on stroke outcomes, and quality improvement in stroke care delivery. Under his leadership, the AHA Get with the Guidelines–Stroke Registry has grown into the world's largest stroke registry with over 8 million patient encounters. Fellow of the American Heart Association Fellow of the American Academy of Neurology Fellow of the American Neurological Association Digital health section editor for Stroke journal Member of Lancet Digital Health international advisory board Dr. Schwamm led the adoption of virtual care for 10,000 clinicians during the first six months of the COVID-19 pandemic, facilitating over 1.7 million virtual visits. He champions redesigning care delivery through a human-centered lens, leveraging technology to improve patient outcomes while reducing healthcare disparities. His educational background includes an AB in Philosophy from Harvard University (1985) and an MD from Harvard Medical School (1991), followed by neurology residency and stroke fellowship at Massachusetts General Hospital.

• Stroke
• Neurology
• Digital Health
• +۶ مورد دیگر

Jens O. Brunner is a Professor of Decision Science in Healthcare at the Technical University of Denmark (DTU), affiliated with the Department of Technology, Management and Economics. Previously, he held a professorship at the University of Augsburg until March 2023 and served as co-director of the University Center for Health Care (UNIKA-T) from 2013 to 2020. He earned his PhD from the TUM School of Management (2009) and a diploma in Business Administration from the University of Mannheim (2006). Roles: Professor, Department Editor for Health Care Management Science , and Associate Editor for multiple journals. Education: PhD in Management, TUM School of Management (2009) Diploma in Business Administration, University of Mannheim (2006) His research focuses on healthcare operations management and the application of quantitative methods to optimize service systems. Key areas include triage policies, staff scheduling, and AI-driven healthcare solutions. His work has contributed to improving resource allocation in hospitals and pandemic response strategies. Notable awards include the Harold W. Kuhn Award (2015) and the IISE/SSE Outstanding Innovation Award (2022). His research has been published in journals like IIE Transactions and European Journal of Operational Research . He supervises PhD students in projects such as AI-integrated pooling strategies and resource optimization in healthcare. His involvement in interdisciplinary collaborations and editorial roles highlights his leadership in advancing healthcare operations research.

• Healthcare Operations Management
• Operations Research
• Analytics
• +۳ مورد دیگر

Dr. Chien-Ming Huang is the John C. Malone Assistant Professor in the Department of Computer Science at Johns Hopkins University. He leads the Intuitive Computing Laboratory and is affiliated with the Malone Center for Engineering in Healthcare, Laboratory for Computational Sensing and Robotics, Institute for Assured Autonomy, and Data Science and AI Institute. His research focuses on human-robot interaction, human-computer interaction, and artificial intelligence applications in healthcare and education. BS in Computer Science, National Chiao Tung University (2006) MS in Computer Science, Georgia Institute of Technology (2010) PhD in Computer Science, University of Wisconsin–Madison (2015) Postdoctoral Research, Yale University (2015-2017) Dr. Huang's work bridges human-robot interaction, robotics, and AI to develop technologies that enhance social, physical, and behavioral support for diverse populations. His research includes adaptive robot systems for autism intervention, aging care technologies, and explainable AI frameworks for medical decision support. Current projects focus on end-user robot programming, socially aware navigation, and conversational agents for health management. His publications span major venues like Science Robotics , HRI, CHI, and ICRA, with recent emphasis on robot error awareness, small talk in collaboration, and AI explanation design for healthcare. Dr. Huang has received numerous accolades including the NSF CAREER Award and John C. Malone Endowed Chair. 2022 NSF CAREER Award John C. Malone Endowed Chair 2013 RSS Best Paper Runner-Up 2012 Human-Robot Interaction Pioneer Dr. Huang mentors PhD, postdoctoral, and undergraduate researchers, emphasizing interdisciplinary collaboration and technical rigor. He serves as Associate Editor for ACM Transactions on Human-Robot Interaction and has organized key conferences including HRI and ICMI. His lab develops systems for robotic assistance in surgical training, home healthcare, and educational contexts.

• Human-Computer Interaction
• Robotics
• Artificial Intelligence
• +۳ مورد دیگر

Thomas G. Costantino, MD, is a Professor in the Department of Emergency Medicine at Lewis Katz School of Medicine at Temple University. He specializes in Emergency Medicine Ultrasound, with a focus on diagnostic imaging, vascular access, and musculoskeletal ultrasound. Dr. Costantino has held academic positions at multiple institutions, including Drexel University and Medical College of Pennsylvania, and has received numerous accolades for teaching excellence and research contributions. Education: MD from University of Michigan School of Medicine Training: Fellowship and Residency in Emergency Medicine at Medical College of Pennsylvania His research involves advancing point-of-care ultrasound (POCUS) techniques in emergency diagnostics, particularly for aortic dissections, pleural effusions, and acute visual complaints. His publications highlight the efficacy of ultrasound-guided procedures over traditional methods. Scientific Awards & Memberships National Alzheimer’s Federation Research Award University of Michigan Alumni Merit Scholarship Excellence in Teaching Awards at Temple, Drexel, and MCP/Hahnemann Medical Schools Fellow of American Academy of Emergency Medicine and American College of Emergency Physicians Dr. Costantino actively contributes to emergency medicine education, including associate editor roles in medical textbooks and ultrasound training programs. His work emphasizes improving diagnostic accuracy and patient outcomes through innovative imaging techniques.

• Emergency Medicine Ultrasound
• Diagnostic Imaging
• Point-of-Care Ultrasound (POCUS)
• +۳ مورد دیگر

Katherine R. Baker, M.D., is a Clinical Associate Professor of Pediatrics at the University of Rochester School of Medicine and Dentistry and part of the University of Rochester Medical Faculty Group (URMFG). She serves as the Director of Practice Innovation for Patient, Family, and Community Engagement at Golisano Children's Hospital Pediatric Practice. Her clinical focus includes newborn care, lactation support, and trauma-informed care. Education: MD from Drexel University College of Medicine (2008) Residency in Pediatrics at University of Wisconsin Hospital and Clinics (2009–2011) Internship in Pediatrics at University of Wisconsin Hospital and Clinics (2008–2009) Dr. Baker’s research emphasizes medical education, physician wellness, and the medical home model. She aims to enhance resident training in well-child and acute care settings, prepare trainees for global health work, and integrate mental health and breastfeeding support into medical home frameworks. Her work also focuses on mitigating burnout and promoting physician wellness. Scientific Awards: American Academy of Pediatrics Clinical Case Presentation Winner (2009) Alpha Omega Alpha Medical Honor Society (2007) Award for Excellence in Program for Integrated Learning (2006) Mary C. Riforgiato Scholarship Recipient (2001–2002) Phi Eta Sigma National Honor Society (1998–2002) New York State Society for Clinical Laboratory Science Student of the Year (1998–2002)

• Medical Education
• Medical Home
• Physician Wellness
• +۳ مورد دیگر

Dr. Richard E. Hayden is a Professor in the Department of Otolaryngology-Head and Neck Surgery at Mayo Clinic College of Medicine and Science, Mayo Clinic, Phoenix, Arizona. He holds leadership roles as Associate Dean at Mayo Clinic School of Health Sciences and Education Director at the Mayo Clinic Center for Regenerative Biotherapeutics. His clinical and academic work centers on head and neck oncology, reconstructive surgery, and regenerative medicine. Dr. Hayden earned his MDCM from McGill University in 1974 and completed fellowships in Head and Neck Surgery-Oncology at M.D. Anderson Hospital and Radiation Oncology at Princess Margaret Hospital. He also holds advanced training in facial plastic surgery. His research spans head and neck cancer, microvascular and reconstructive surgery, transoral laser microsurgery, and regenerative medicine. He has pioneered techniques in flap reconstruction and contributed significantly to understanding postoperative outcomes and surgical innovations. His work emphasizes oncologic safety, functional preservation, and minimally invasive approaches. His recent publications (2018–2024) reflect a strong focus on transoral surgery, flap reconstruction (including submental and free flaps), mucosal-sparing radiation, and regenerative medicine education. Themes include surgical outcomes, reconstructive innovation, and interdisciplinary training in emerging therapies like CAR-T cells and regenerative healthcare. Dean's Award, Mayo Clinic Graduate School of Biomedical Sciences (2022) Distinguished Educator Award, Mayo Clinic Arizona (2016) Distinguished Service Award, American Academy of Otolaryngology - Head and Neck Surgery (2006) Honorary Member, German Society of Laryngology-Head and Neck Surgery (2007) Multiple Visiting Professorships and Keynote Speaker invitations Dr. Hayden has mentored numerous trainees and led major educational initiatives, including regenerative medicine and CAR-T curricula. He has held leadership positions such as Chair of Otolaryngology (2002–2014) and active roles in national societies. His research is supported by institutional affiliations and collaborative grants, particularly in regenerative biotherapeutics. He is involved in multiple labs and teams focused on head and neck reconstruction, surgical innovation, and regenerative medicine translation.

• Head and Neck Surgery
• Head and Neck Oncology
• Endocrine Surgery
• +۷ مورد دیگر

Philip Boone, MD, PhD, is an Attending Physician in the Division of Genetics and Genomics at Boston Children's Hospital and an Instructor of Pediatrics at Harvard Medical School. He specializes in medical genetics with particular expertise in rare disorders, medical mysteries, deletion and duplication syndromes, and Cornelia de Lange syndrome. Dr. Boone sees patients at Boston Children's Brookline location (2 Brookline Place, 7th Floor) and provides comprehensive genetic care including diagnostics, counseling, and individualized management. Stanford University (Undergraduate, 2006) Baylor College of Medicine (Graduate & Medical School, 2013-2014) Boston Combined Residency Program (Internship & Residency, 2016-2020) Harvard Medical School Genetics Training Program (Fellowship, 2020) Dr. Boone's research focuses on neurodevelopmental disorders, chromatin regulation, and genetic diagnostics. His work spans from fundamental genetic mechanisms to clinical applications, with particular emphasis on cohesinopathies including Cornelia de Lange syndrome. He has contributed significantly to understanding genetic variants associated with growth disorders, developmental features, and structural chromosomal abnormalities. His research combines advanced genomic technologies with clinical insights to improve diagnosis and management of rare genetic conditions. Analysis of Dr. Boone's publication record reveals a strong focus on medical genetics with emphasis on neurodevelopmental disorders, chromatin regulation, and genetic diagnostics. His work spans basic research on gene function and regulation to clinical applications in rare disease diagnosis. A notable trend is his investigation of cohesin complex disorders, particularly SMC3 variants and their relationship to Cornelia de Lange syndrome. His publications demonstrate expertise in both traditional genetic analysis and cutting-edge genomic technologies including long-read sequencing and telomere-to-telomere assembly. Dr. Boone actively contributes to medical education through publications on genetic diagnostics and distance learning resources for medical genetics. He has co-authored educational materials that help advance the field's knowledge base and training capabilities. As an attending physician in the Division of Genetics and Genomics at Boston Children's Hospital and a research fellow in the Center for Genomic Medicine at Massachusetts General Hospital, Dr. Boone works within one of the largest pediatric genetics practices in the country. The division includes over 30 board-certified clinical geneticists, genetic counselors, dieticians, and nursing staff who provide comprehensive care for patients with both common and extremely rare genetic conditions.

• Medical Genetics
• Genomics
• Pediatric Genetics
• +۴ مورد دیگر